Study Stopped
Lack of patients
Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 Mutation
EnteroLarc
1 other identifier
interventional
19
1 country
1
Brief Summary
The clinical and pathological similarities between LRRK2 related parkinsonism and idiopathic Parkinson's disease (PD) indicate that monogenetic LRRK2 parkinsonism may be a paradigm for the development of Lewy bodies disease, and a careful look at discrepancies between these two conditions may provide insight into the pathogenesis of PD. The early involvement of the enteric nervous system (ENS) during PD led to theories that an as yet unidentified external agent entering the ENS causes PD . If lesions of the ENS are found in patients who present with a genetic form of parkinsonism would go against this notion, and thus provide insight to the pathophysiology of the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 11, 2012
CompletedFirst Posted
Study publicly available on registry
June 13, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedDecember 1, 2016
November 1, 2016
1.6 years
June 11, 2012
November 30, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of alpha-synuclein aggregates in colonic biopsies using immunohistochemistry
3 months
Secondary Outcomes (1)
Analysis of intestinal permeability in biopsies using Ussing's chambers
3 months
Study Arms (1)
Colonic biopsies
OTHERColonic biopsies obtained during the course of colonoscopy or rectosigmoidoscopy
Interventions
Eligibility Criteria
You may qualify if:
- Patients aged 30-80, both genders
- Parkinson's disease patients
- Parkinson's disease patients with G2019S mutations
- Controls: patient at risk of colic cancer for whom a coloscopy is required
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
Nantes, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tiphaine ROUAUD, Doctor
Nantes University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2012
First Posted
June 13, 2012
Study Start
March 1, 2012
Primary Completion
October 1, 2013
Study Completion
October 1, 2013
Last Updated
December 1, 2016
Record last verified: 2016-11